Skip to content

Effects of morning and bedtime administration of azisartan on nocturnal blood pressure control in patients with obstructive sleep apnea-related hypertension

Effects of morning and bedtime administration of azisartan on nocturnal blood pressure control in patients with obstructive sleep apnea-related hypertension

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071098
Enrollment
Unknown
Registered
2023-05-05
Start date
2023-05-05
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

1:Morning medication (6 -10:00 am) + bedtime placebo (20:00-22:00 pm)
2:Morning placebo (6:00-10:00 am) + bedtime medication (20:00-22:00 pm)

Sponsors

The First Affiliated Hospital of USTC (Anhui Provincial Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Case selection criteria:? age 18 years old, gender unlimited, regular schedule and rest time; ?not receiving antihypertensive treatment or stopping antihypertensive drugs for more than 2 weeks; ? signing informed consent form and being able to participate in follow-up on time. ?Compliance with the diagnostic criteria of hypertension: referring to the China guidelines for Prevention and treatment of Hypertension (2018 Edition), the diagnostic criteria of hypertension are as follows: without antihypertensive drugs, the clinic blood pressure, systolic blood pressure = 140mmHg and / or diastolic blood pressure = 90mmHg were measured three times in different days. The patient has a history of hypertension and is currently using antihypertensive drugs. Although the blood pressure is lower than 140/90mmHg, it should still be diagnosed as hypertension. At the same time, 24-hour ambulatory blood pressure monitoring was performed, and the nocturnal blood pressure of the selected patients was = 120/70mmHg. ? in accordance with the OSAHS diagnostic criteria of the sleep apnea group of the Respiratory Society of the Chinese Medical Association in 2012, there were typical nocturnal snoring with apnea, daytime sleepiness [Epworth sleepiness scale (EpworthsleepinessscaleESS) score = 9] and other symptoms. Physical examination showed stenosis and obstruction in any part of the upper airway, apnea hypopnea index (AHI) = 5 / h. Or daytime sleepiness was not obvious (ESS score < 9), AHI = 10 times / h or one or more OSA complications (cognitive impairment, hypertension, coronary heart disease, etc.).

Exclusion criteria

Exclusion criteria: ?Planned pregnancy or pregnancy or lactation women; ?Bilateral renal artery stenosis; ? Hyperkalemia (serum potassium > 5.5mmol/L), chronic renal insufficiency (creatinine>265umol/L); ?Malignant hypertension, hypertensive emergency or subemergency, hypertensive crisis and hypertensive encephalopathy; ?history of angioedema, drug-related or other causes; or history of allergy to angiotensin receptor antagonists, angiotensin converting enzyme inhibitors or renin inhibitors; ? history of alcoholism or drug addiction; ?working night shifts or shifts; ?cardiovascular disease and some related diseases, such as unstable angina pectoris, heart failure, life-threatening arrhythmias, atrial fibrillation, renal failure and III-IV grade retinopathy; ? deep dipper blood pressure; ?people who cannot tolerate ambulatory blood pressure measurements and other situations that cannot participate in clinical studies.

Design outcomes

Primary

MeasureTime frame
Reduction of nocturnal mean systolic blood pressure;

Secondary

MeasureTime frame
24-hour ambulatory blood pressure;Clinic blood pressure;

Countries

China

Contacts

Public ContactXiaofan Yu

The First Affiliated Hospital of USTC (Anhui Provincial Hospital)

501183943@qq.com+86 13365741273

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026